These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34942102)

  • 41. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overview of the COVID-19 Pandemic in Japan: Public Health Perspectives in the first half of 2020.
    Suzuki Y
    Keio J Med; 2021 Dec; 70(4):73-81. PubMed ID: 34602536
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.
    Trouillet-Assant S; Albert Vega C; Bal A; Nazare JA; Fascia P; Paul A; Massardier-Pilonchery A; D Aubarede C; Guibert N; Pitiot V; Lahousse M; Boibieux A; Makhloufi D; Simon C; Rabilloud M; Trabaud MA; Gueyffier F; Fassier JB;
    BMJ Open; 2020 Nov; 10(11):e041268. PubMed ID: 33234651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Containing pandemics through targeted testing of households.
    Voigt A; Martyushenko N; Karlsen E; Hall M; Nyhamar K; Omholt SW; Almaas E
    BMC Infect Dis; 2021 Jun; 21(1):548. PubMed ID: 34107917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mass testing for covid-19 in the UK.
    Gill M; Gray M
    BMJ; 2020 Nov; 371():m4436. PubMed ID: 33199289
    [No Abstract]   [Full Text] [Related]  

  • 46. SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States.
    Thomas E; Delabat S; Carattini YL; Andrews DM
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960762
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19 Pandemic and Virtual Clinics for Diabetes Care.
    Garg SK; Reinicke T
    Diabetes Technol Ther; 2021 Jun; 23(S2):S3-S15. PubMed ID: 34061640
    [No Abstract]   [Full Text] [Related]  

  • 48. COVID-19 pandemic predictions using the modified Bateman SIZ model and observational data for Heidelberg, Germany: Effect of vaccination with a SARS-CoV-2 vaccine, coronavirus testing and application of the Corona-Warn-App.
    Braun P; Haffner S; Woodcock BG
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):417-425. PubMed ID: 32646540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.
    Raturi M; Kusum A; Kala M; Mittal G; Sharma A; Bansal N
    Transfus Clin Biol; 2021 Aug; 28(3):300-302. PubMed ID: 33971318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging Telemedicine Tools for Remote COVID-19 Diagnosis, Monitoring, and Management.
    Lukas H; Xu C; Yu Y; Gao W
    ACS Nano; 2020 Dec; 14(12):16180-16193. PubMed ID: 33314910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Could expanding the covid-19 case definition improve the UK's pandemic response?
    Crozier A; Dunning J; Rajan S; Semple MG; Buchan IE
    BMJ; 2021 Jun; 374():n1625. PubMed ID: 34193527
    [No Abstract]   [Full Text] [Related]  

  • 52. Scaled testing for COVID-19 needs community involvement.
    Adams ER; Wolday D; Denkinger CM; Krishna S; de Wit TFR
    J Glob Health; 2021 Mar; 11():03033. PubMed ID: 33763209
    [No Abstract]   [Full Text] [Related]  

  • 53. Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research.
    DiSantostefano RL; Terris-Prestholt F
    Patient; 2021 May; 14(3):303-307. PubMed ID: 33886102
    [No Abstract]   [Full Text] [Related]  

  • 54. ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing.
    Kumar M; Iyer SS
    Expert Rev Mol Diagn; 2021 Apr; 21(4):349-362. PubMed ID: 33706663
    [No Abstract]   [Full Text] [Related]  

  • 55. Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success.
    Greninger AL
    Curr Opin Virol; 2021 Aug; 49():111-116. PubMed ID: 34116392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review.
    Purba AKR; Rosyid AN; Handayani S; Rachman BE; Romdhoni AC; Al Farabi MJ; Wahyuhadi J; Prananingtias R; Rahayu AN; Alkaff FF; Azmi YA; Prasetyo S; Nadjib M; Gutjahr LP; Humaidy RF
    Med Sci Monit; 2024 Apr; 30():e943863. PubMed ID: 38643358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of testing criteria for infectious disease surveillance: The case of COVID-19 in Norway.
    Engebretsen S; Aldrin M
    PLoS One; 2024; 19(8):e0308978. PubMed ID: 39146327
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letter to the Editor: Implementation of Patient Screening in Ambulatory Settings During the COVID-19 Pandemic.
    Pashankar DS; Follo M; Zhao AM; Saeri M; Khokhar B
    J Ambul Care Manage; 2021 Oct-Dec 01; 44(4):331-335. PubMed ID: 34120123
    [No Abstract]   [Full Text] [Related]  

  • 59. Public health-focused use of COVID-19 rapid antigen and PCR tests.
    Woodbridge Y; Goldberg Y; Amit S; Kopelman NM; Mandel M; Huppert A
    Sci Rep; 2024 Jan; 14(1):1430. PubMed ID: 38228695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The defense of Shangri-La: Protecting isolated communities by periodic infection screening in the worst future pandemic.
    Duan A; Li J; Yang Z; He Y
    Infect Genet Evol; 2023 Sep; 113():105479. PubMed ID: 37437767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.